Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Crossref DOI link: https://doi.org/10.1007/s40744-021-00351-7
Published Online: 2021-09-03
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Askanase, Anca D.
Wright, Dale
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
Text and Data Mining valid from 2021-09-03
Version of Record valid from 2021-09-03
Article History
Received: 11 February 2021
Accepted: 13 July 2021
First Online: 3 September 2021